Inicio>>Isotope-Labeled Compounds>> Deuterium>>JWH 081 N-(4-hydroxypentyl) metabolite-d5

JWH 081 N-(4-hydroxypentyl) metabolite-d5

Catalog No.GC47502

A neuropeptide with diverse biological activities

Products are for research use only. Not for human use. We do not sell to patients.

JWH 081 N-(4-hydroxypentyl) metabolite-d5 Chemical Structure

Cas No.: 2747916-00-1

Tamaño Precio Disponibilidad Cantidad
500 μg
214,00 $
Disponible
1 mg
408,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

JWH 081 N-(4-hydroxypentyl) metabolite-d5 contains five deuterium atoms at the 2, 4, 5, 6, and 7 positions. It is intended for use as an internal standard for the quantification of JWH 081 N-(4-hydroxypentyl) metabolite by GC- or LC-MS. JWH 081 N-(4-hydroxypentyl) metabolite is an expected product of the phase I metabolism of JWH 081 , based on studies on the metabolism of the related synthetic cannabinoids JWH 018 and JWH 073 .1,2

1.Wintermeyer, A., MÖller, I., Thevis, M., et al.In vitro phase I metabolism of the synthetic cannabimimetic JWH-018Anal. Bioanal. Chem.398(5)2141-2153(2010) 2.Chimalakonda, K.C., Moran, C.L., Kennedy, P.D., et al.Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urineAnal. Chem.83(16)6381-6388(2011)

Reseñas

Review for JWH 081 N-(4-hydroxypentyl) metabolite-d5

Average Rating: 5 ★★★★★ (Based on Reviews and 16 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for JWH 081 N-(4-hydroxypentyl) metabolite-d5

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.